Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jan;26(1):e182-e185.
doi: 10.1634/theoncologist.2020-0572. Epub 2020 Sep 7.

Cancer and Risk of COVID-19 Through a General Community Survey

Karla A Lee #  1 , Wenjie Ma #  2 , Daniel R Sikavi  3 , David A Drew  2 , Long H Nguyen  2 , Ruth C E Bowyer  1 , M Jorge Cardoso  4 , Tove Fall  5   6 , Maxim B Freidin  1 , Maria Gomez  5 , Mark Graham  4 , Chuan-Guo Guo  2 , Amit D Joshi  2 , Sohee Kwon  2 , Chun-Han Lo  2 , Mary Ni Lochlainn  1 , Cristina Menni  1 , Benjamin Murray  4 , Raaj Mehta  2 , Mingyang Song  2 , Carole H Sudre  4 , Veronique Bataille  1 , Thomas Varsavsky  4 , Alessia Visconti  1 , Paul W Franks  5 , Jonathan Wolf  7 , Claire J Steves  1 , Sebastien Ourselin  4 , Tim D Spector  1 , Andrew T Chan  2   8   9 ; COPE consortium
Affiliations

Cancer and Risk of COVID-19 Through a General Community Survey

Karla A Lee et al. Oncologist. 2021 Jan.

Abstract

Individuals with cancer may be at high risk for coronavirus disease 2019 (COVID-19) and adverse outcomes. However, evidence from large population-based studies examining whether cancer and cancer-related therapy exacerbates the risk of COVID-19 infection is still limited. Data were collected from the COVID Symptom Study smartphone application since March 29 through May 8, 2020. Among 23,266 participants with cancer and 1,784,293 without cancer, we documented 10,404 reports of a positive COVID-19 test. Compared with participants without cancer, those living with cancer had a 60% increased risk of a positive COVID-19 test. Among patients with cancer, current treatment with chemotherapy or immunotherapy was associated with a 2.2-fold increased risk of a positive test. The association between cancer and COVID-19 infection was stronger among participants >65 years and males. Future studies are needed to identify subgroups by tumor types and treatment regimens who are particularly at risk for COVID-19 infection and adverse outcomes.

PubMed Disclaimer

Conflict of interest statement

Disclosures of potential conflicts of interest may be found at the end of this article.

David A. Drew: Zoe Global Ltd. (RF); Jonathan Wolf: Zoe Global Ltd. (E, OI); Tim D. Spector: Zoe Global Ltd. (C/A); Andrew T. Chan: Zoe Global Ltd. (RF). The other authors indicated no financial relationships.

(C/A) Consulting/advisory relationship; (RF) Research funding; (E) Employment; (ET) Expert testimony; (H) Honoraria received; (OI) Ownership interests; (IP) Intellectual property rights/inventor/patent holder; (SAB) Scientific advisory board

Comment in

References

    1. Drew DA, Nguyen LH, Steves CJ et al. Rapid implementation of mobile technology for real‐time epidemiology of COVID‐19. Science 2020;368:1362–1367. - PMC - PubMed
    1. Menni C, Valdes AM, Freidin MB et al. Real‐time tracking of self‐reported symptoms to predict potential COVID‐19. Nat Med 2020;26:1037–1040. - PMC - PubMed
    1. Dai M, Liu D, Liu M et al. Patients with cancer appear more vulnerable to SARS‐CoV‐2: A multicenter study during the COVID‐19 outbreak. Cancer Discov 2020;10:783–791. - PMC - PubMed
    1. Liang W, Guan W, Chen R et al. Cancer patients in SARS‐CoV‐2 infection: A nationwide analysis in China. Lancet Oncol 2020;21:335–337. - PMC - PubMed
    1. Miyashita H, Mikami T, Chopra N et al. Do patients with cancer have a poorer prognosis of COVID‐19? An experience in New York City. Ann Oncol 2020;31:1088–1089. - PMC - PubMed

Publication types

MeSH terms

Substances